Projects per year
Personal profile
Education
- 2002 Ph.D. National Taiwan University
- 1994 M.S. Taipei Medical University
Experience
- 2020- Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2019- Director, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2016-2018 Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2016 Associate Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2008-2013 Assistant Professor, Department of Pharmacology, Taipei Medical University
- 2009-2013 Assistant Investigator, National Health Research Institutes
- 2007-2009 Assistant Investigator, National Taiwan University
- 2002-2007 Postdoctor, National Taiwan Universiy
- 1994-1998 Teaching Assistant, Chang-Gung University
Research Interests
- Drug Discovery
- Disease animal model
- Pharmacology
URL
Awards
- 2019 Single Research Project Budget Award, Taipei Medical University
Fingerprint Dive into the research topics where Shiow-Lin Pan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
新穎性選擇性HDAC抑制劑之抗癌藥物開發與藥理機轉探討(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
The Role of Protein Kinase CK1 and The Mechanism of Inhibitors on Glioblastoma Cells
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
以體內及體外試驗來進行SYRK1B抑制劑之毒理學評估
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
Drug Discovery and Pharmacological Investigation of Novel Selective Hdac Inhibitors as Anticancer Drugs
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
選擇性抗癌標靶藥物HDAC6抑制劑臨床前試驗研究(II)
5/1/19 → 1/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors
Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., Dec 1 2020, In : Scientific Reports. 10, 1, 10510.Research output: Contribution to journal › Article
Open Access
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
Chang, F. L., Tsai, K. C., Lin, T. Y., Yang, T. W., Lo, Y. N., Chen, W. C., Chang, J. H., Lu, M. K., Chiou, C. T., Chen, P. H., Yen, Y., Pan, S. L. & Lee, Y. C., Jan 1 2020, In : BioMed Research International. 2020, 3415471.Research output: Contribution to journal › Article
Open Access
4
Citations
(Scopus)
Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells (Oncogenesis, (2017), 6, 7, (e359), 10.1038/oncsis.2017.61)
Huang, H. L., Wu, H. Y., Chu, P. C., Lai, I. L., Huang, P. H., Kulp, S. K., Pan, S. L., Teng, C. M. & Chen, C. S., Feb 1 2020, In : Oncogenesis. 9, 2, 27.Research output: Contribution to journal › Comment/debate
Open Access
Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))
Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M. & Pan, S. L., Jan 15 2020, In : Toxicology and Applied Pharmacology. 387, 114858.Research output: Contribution to journal › Comment/debate
Open Access
Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)
Liu, Y. M., HuangFu, W. C., Huang, H. L., Wu, W. C., Chen, Y. L., Yen, Y., Huang, H. L., Nien, C. Y., Lai, M. J., Pan, S. L. & Liou, J. P., Sep 15 2020, In : European Journal of Medicinal Chemistry. 202, 112633.Research output: Contribution to journal › Comment/debate
Open Access